Background De novo posttransplant malignancy (PTM) is a serious complication of
transplantation. Incidences may vary among solid organ transplantations (SOTs) and may …

Cancer is a significant cause of morbidity and mortality after solid organ transplantation
(SOT) and related to lifelong immunosuppression. This retrospective registry study assessed …

Post-transplant lymphoproliferative disorders (PTLDs) represent the most severe
complication of both solid organ and hematopoietic stem cell transplantation. The Epstein …

Consistent induction of donor-specific unresponsiveness in the absence of continuous
immunosuppressive therapy and toxic effects remains a difficult task in clinical organ …

Malignancy is the second most common single cause of death observed in organ transplant
recipients. The excess cancer risk is related to intensity and duration of immunosuppressive …

Background Solid organ transplant recipients are at increased risk of cancer due to long-
term immunosuppression. Immune-checkpoint inhibitors (ICI) showed clinical benefits but …

Background Patients with ESRD have a substantially increased cancer risk, but few studies
have examined the patterns of cancer mortality along a patient's journey from dialysis to …

Abstract Exposure to Adverse Childhood Experiences (ACEs) is associated with a host of
harmful outcomes, including increased risk for cancer. A scoping review was conducted to …

BACKGROUND Solid organ transplantation recipients have elevated cancer incidence.
Estimates of absolute cancer risk after transplantation can inform prevention and screening …

Background There is a concern that topical tacrolimus and pimecrolimus, indicated for
second-line treatment of atopic dermatitis, may increase the risk of lymphoma and skin …